World's Best Scientists 2026 revealed!
Award Badge
Immunology
Spain
2026
Award Badge
Medicine
Spain
2023

D-Index & Metrics

Immunology

D-Index
116
Citations
72381
World Ranking
371
National Ranking
4

Medicine

D-Index
117
Citations
72873
World Ranking
4125
National Ranking
57

Ricard Cervera publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ricard Cervera sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 544 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ricard Cervera D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ricard Cervera sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 116 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Spain Leader Award
  • 2025 - Research.com Immunology in Spain Leader Award
  • 2023 - Research.com Medicine in Spain Leader Award
  • 2022 - Research.com Immunology in Spain Leader Award

Overview

Ricard Cervera is affiliated with the University of Barcelona in Spain and has made numerous contributions to the field of medicine, with a primary focus on rheumatology and systemic autoimmune diseases. Their research spans multiple interconnected subfields, including immunology, hematology, genetics, and nephrology.

The scientist's work extensively covers topics such as systemic lupus erythematosus research, platelet disorders and treatments, renal diseases and glomerulopathies, atherosclerosis and cardiovascular diseases, systemic sclerosis and related diseases, diabetes and associated disorders, as well as blood disorders and treatments.

Among the recent papers published by Ricard Cervera are:

  • EULAR recommendations for the management of systemic lupus erythematosus: 2023 update, 2023, Annals of the Rheumatic Diseases
  • The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, 2023, Arthritis & Rheumatology
  • 2023 ACR/EULAR antiphospholipid syndrome classification criteria, 2023, Annals of the Rheumatic Diseases
  • 2021 DORIS definition of remission in SLE: final recommendations from an international task force, 2021, Lupus Science & Medicine
  • Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases, 2020, Arthritis & Rheumatology

Ricard Cervera frequently collaborates with several coauthors who contribute to the breadth of their research output. These collaborators include Gerard Espinosa, Ignasi Rodríguez-Pintó, Maria Gerosa, Maria G. Tektonidou, and Savino Sciascia.

Their publications are often found in a set of recurring venues that are active in rheumatology and autoimmune disease research:

  • Annals of the Rheumatic Diseases
  • Autoimmunity Reviews
  • Lupus
  • Lara D. Veeken
  • Revista Colombiana de Reumatología

The main field of study for Ricard Cervera is medicine, with a significant concentration on rheumatology, as evidenced by 155 publications in that subfield alone. Immunology, hematology, genetics, and nephrology also represent substantial parts of their research profile.

Best Publications

  • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

    S. Miyakis;M. D. Lockshin;T. Atsumi;D. W. Branch

  • 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    Martin Aringer;Karen Costenbader;David Daikh;Ralph Brinks

  • Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

    Ricard Cervera;Jean Charles Piette;Josep Font;Munther A. Khamashta

  • 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

    Antonis Fanouriakis;Myrto Kostopoulou;Alessia Alunno;Martin Aringer

  • A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

    Richard Furie;Michelle Petri;Omid Zamani;Ricard Cervera

  • Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients

    Ricard Cervera;Munther A. Khamashta;Josep Font;Gian Domenico Sebastiani

  • Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

    Gerald B. Appel;Gabriel Contreras;Mary Anne Dooley;Ellen M. Ginzler

  • Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.

    Frédéric A. Houssiau;Carlos Vasconcelos;David D'Cruz;Gian Domenico Sebastiani

  • Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus

    Cervera R;Khamashta Ma;Font J;Sebastiani Gd

  • Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

    George K Bertsias;Maria Tektonidou;Zahir Amoura;Martin Aringer

  • EULAR recommendations for the management of antiphospholipid syndrome in adults

    Maria G Tektonidou;Laura Andreoli;Marteen Limper;Zahir Amoura

  • Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines

    R A Asherson;R Cervera;P G de Groot;D Erkan

  • EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

    G. Bertsias;J. P. A. Ioannidis;J. Boletis;S. Bombardieri

  • EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

    G K Bertsias;J P A Ioannidis;M Aringer;E Bollen

  • Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

    R. Cervera;M. A. Khamashta;Y. Shoenfeld;M. T. Camps

  • Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

    Ronald van Vollenhoven;Marta Mosca;George Bertsias;David Isenberg

  • Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment.

    Ronald A. Asherson;Gerard Espinosa;Ricard Cervera;Josep Font

  • EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

    S van Assen;N Agmon-Levin;O Elkayam;R Cervera

  • Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients.

    Ronald A. Asherson;Ricard Cervera;Jean-Charles Piette;Josep Font

  • International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

    Nancy Agmon-Levin;Nancy Agmon-Levin;Jan Damoiseaux;Cornelis Kallenberg;Ulrich Sack

  • Anti-inflammatory and immunosuppressive drugs and reproduction.

    Monika Østensen;Munther Khamashta;Michael Lockshin;Ann Parke

Frequent Co-Authors

Gerard Espinosa
Gerard Espinosa University of Barcelona
Miguel Ingelmo
Miguel Ingelmo University of Barcelona
Josep Font
Josep Font University of Barcelona
Manuel Ramos-Casals
Manuel Ramos-Casals Hospital Clinic of Barcelona
Yehuda Shoenfeld
Yehuda Shoenfeld Sheba Medical Center
Ronald A. Asherson
Ronald A. Asherson University of the Witwatersrand
Pier Luigi Meroni
Pier Luigi Meroni Istituto Auxologico Italiano
Angela Tincani
Angela Tincani University of Brescia
Andrea Doria
Andrea Doria University of Padua
Munther A. Khamashta
Munther A. Khamashta King's College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens diverse career pathways, especially when coupled with nursing and healthcare credentials. Those interested in advancing their nursing careers may explore options like accelerated nurse practitioner programs online, which offer a fast track to becoming a nurse practitioner while balancing current commitments.

For nurses aiming to specialize further, transitioning from a family nurse practitioner (FNP) to an acute care nurse practitioner (ACNP) can be facilitated through an fnp to acnp bridge program online. These programs provide the necessary clinical skills and knowledge in critical care, making them ideal for immunology professionals working with complex patient cases.

Entry-level candidates or those switching careers can benefit from online BSN programs for non nurses. These degrees equip students with foundational nursing skills applicable in immunology research, diagnostics, and patient care, often with flexible schedules to suit various lifestyles.

Transparency in compensation is important when selecting a career path. Exploring dnp salary transparency resources helps prospective students understand the financial outlook of Doctor of Nursing Practice roles across different states, aiding informed decisions about education investments.

Best Scientists Citing Ricard Cervera

Trending Scientists

Recently Published Articles